Literature DB >> 29676839

Analgesic consumption trajectories in 8975 patients 1 year after fast-track total hip or knee arthroplasty.

C C Jørgensen1,2, M Petersen3, H Kehlet1,2, E K Aasvang1,4.   

Abstract

BACKGROUND: Persistent or increased long-term opioid consumption has previously been described following total hip- (THA) and knee arthroplasty (TKA). However, detailed information on postoperative analgesic consumption trajectories and risk factors associated with continued need of analgesics in fast-track THA and TKA is sparse.
METHODS: This is a descriptive multicentre study in primary unilateral fast-track THA or TKA with prospective data on patient characteristics and information on reimbursement entitled dispensed prescriptions of paracetamol, non-steroidal anti-inflammatory drugs, opioids, anticonvulsants and antidepressants 1 month preoperatively and 1 year postoperatively. Patients were stratified according to preoperative opioid use. Postoperative analgesic consumption trajectories were stratified as increased, decreased or no use compared to the preoperative period.
RESULTS: Of 8975 patients (4849 THA/4126 TKA), 33.9% had relevant reimbursed prescriptions 9-12 months postoperatively. Of 2136 (23.8%) patients with preoperative opioid use, 3.4% had unchanged opioid consumption at 9-12 months postoperatively. However, increased opioid consumption after 9-12 months occurred in 17.6 (TKA) and 10.2% (THA) compared to 9.9 and 6.3% in opioid-naive TKA and THA patients, respectively. Increased NSAID and paracetamol use was seen in 11.5 and 12.4% of all patients. Preoperative analgesic use (any), TKA, psychiatric disorder, tobacco abuse, cardiac disease and use of walking aids were associated with increased opioid consumption.
CONCLUSION: Continued and increased opioid and other analgesic use occur in a clinically significant proportion of fast-track TKA and THA patients 9-12 months postoperatively, suggesting treatment failure and need for early intervention. Preoperative risk assessment may allow identification of patients in risk of increased postoperative opioid consumption. SIGNIFICANCE: We found a considerable fraction of patients with continued or increased opioid consumption 9-12 months after fast-track THA and TKA. Increase in opioid consumption was more frequent in preoperative opioid users than opioid-naive patients, but a pattern of increased analgesic consumption was present across all analgesics. Our data demonstrate a need for increased focus on long-term analgesic strategies and postoperative follow-up after THA and TKA, especially in preoperative opioid users.
© 2018 European Pain Federation - EFIC®.

Entities:  

Year:  2018        PMID: 29676839     DOI: 10.1002/ejp.1232

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  12 in total

1.  Pain medication purchases before and after total hip and knee arthroplasty: a register study of 329,743 arthroplasties.

Authors:  Ville Turppo; Reijo Sund; Jukka Huopio; Heikki Kröger; Joonas Sirola
Journal:  Acta Orthop       Date:  2022-06-08       Impact factor: 3.925

2.  Effect of Intravenous Paracetamol on Opioid Consumption in Multimodal Analgesia After Lumbar Disc Surgery: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Feng Yin; Xiu-Hong Wang; Fei Liu
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

Review 3.  Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges.

Authors:  Pamela E Macintyre; Lindy J Roberts; Christine A Huxtable
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546

4.  Is the Preoperative Use of Antidepressants and Benzodiazepines Associated with Opioid and Other Analgesic Use After Hip and Knee Arthroplasty?

Authors:  Tuomas J Rajamäki; Teemu Moilanen; Pia A Puolakka; Aki Hietaharju; Esa Jämsen
Journal:  Clin Orthop Relat Res       Date:  2021-10-01       Impact factor: 4.755

5.  Predictors of the use of analgesic drugs 1 year after joint replacement: a single-center analysis of 13,000 hip and knee replacements.

Authors:  Tuomas Jaakko Rajamäki; Pia A Puolakka; Aki Hietaharju; Teemu Moilanen; Esa Jämsen
Journal:  Arthritis Res Ther       Date:  2020-04-21       Impact factor: 5.156

6.  Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): A prospective, assessor-blind, randomized controlled pilot trial.

Authors:  Jennifer M Hah; Jodie A Trafton; Balasubramanian Narasimhan; Partha Krishnamurthy; Heather Hilmoe; Yasamin Sharifzadeh; James I Huddleston; Derek Amanatullah; William J Maloney; Stuart Goodman; Ian Carroll; Sean C Mackey
Journal:  EClinicalMedicine       Date:  2020-10-16

7.  Worse patient-reported outcomes and higher risk of reoperation and adverse events after total hip replacement in patients with opioid use in the year before surgery: a Swedish register-based study on 80,483 patients.

Authors:  Johan Simonsson; Erik Bülow; Karin Svensson Malchau; Fredrik Nyberg; Urban Berg; Ola Rolfson
Journal:  Acta Orthop       Date:  2022-01-03       Impact factor: 3.717

8.  Do we have an opioid crisis in Scandinavia? Time to act?

Authors:  Marcus Heilig; Magnus Tägil
Journal:  Acta Orthop       Date:  2018-05-01       Impact factor: 3.717

9.  Combination of post-fascia iliaca compartment block and dexmedetomidine in pain and inflammation control after total hip arthroplasty for elder patients: a randomized control study.

Authors:  Xiaofen Liu; Xianwen Hu; Rui Li; Ye Zhang
Journal:  J Orthop Surg Res       Date:  2020-02-10       Impact factor: 2.359

10.  Perioperative prevention of persistent pain after total hip and knee arthroplasty-Protocol for two systematic reviews.

Authors:  Jens Laigaard; Anders Karlsen; Mathias Maagaard; Lukas Kristian Rosenberg; Andreas Creutzburg; Troels Haxholdt Lunn; Ole Mathiesen; Søren Overgaard
Journal:  Acta Anaesthesiol Scand       Date:  2022-03-31       Impact factor: 2.274

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.